by | May 19, 2024 | Advanced Pharmacology - Care of the Family
A 51-year-old cisgender man with chronic HIV and a long history of heroin use has been stable on a methadone dose of 80 mg daily. He has taken efavirenz-tenofovir DF-emtricitabine for 9 years with suppressed HIV RNA levels, but he recently developed depression. He...
by | May 19, 2024 | Advanced Pharmacology - Care of the Family
A patient is newly diagnosed with HIV and has a history of previously receiving cabotegravir for preexposure prophylaxis. Results from a standard genotype resistance assay and integrase resistance genotype are pending. Which one of the initial antiretroviral regimens...
by | May 19, 2024 | Advanced Pharmacology - Care of the Family
According to the Adult and Adolescent ART Guidelines, which one of the following is classified as a recommended initial regimen for most people with HIV (presume no history of receiving cabotegravir for preexposure prophylaxis)? Dolutegravir plus tenofovir...
by | May 19, 2024 | Advanced Pharmacology - Care of the Family
Which one of the following antiretroviral medications requires an acidic environment for absorption and is contraindicated for use with a proton-pump inhibitor? Fostemsavir Bictegravir Doravirine Rilpivirine
by | May 19, 2024 | Advanced Pharmacology - Care of the Family
Which superfamily of enzymes is responsible for the metabolism of more than half of all antiretroviral medications? CYP2D6 UDP-glucuronosyltransferase P-glycoprotein CYP3A (P450)
by | May 19, 2024 | Advanced Pharmacology - Care of the Family
Which one of the following antiretroviral medications binds to a human cell surface receptor? Dolutegravir Ibalizumab Darunavir Emtricitabine
